| |
|
|
|
HTG Molecular Diagnostics- Inc.
|
|
2.78 +0.53 (+23.56%) |
10/23/2017 4:00pm |
|
Open: |
2.30 |
Pre close: |
2.25 |
Target:
|
3.43 
|
|
High: |
2.94 |
Low: |
2.30 |
Resistance:
|
2.94
3.43
|
|
Volume: |
4,056,237 |
Market Cap: |
31.83M |
Support:
|
2.14
1.65
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.43
|
MACD |
MACD(12,26):
|
0.15 |
|
MA(20): |
2.02 |
Signal(12,26,9): |
0.07 |
|
MA(100): |
2.30  |
Stochastic Oscillator |
%K(14,3):
|
72.40 |
|
MA(250): |
2.77 |
%D(3): |
73.24 |
|
Average Volume(K) |
3-Month: |
64204
|
52-Week |
High:
|
13.25 |
|
10-Days: |
106300 |
Low: |
1.20 |
|
RSI |
RSI(14):
|
70.96 |
Change(%): |
11.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.950 |
Return on Equity (ttm) |
-1928.8 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
-2.290 |
Return on Assets (ttm) |
-54.2 |
Shares Float (M) |
8.82 |
|
EPS Est. Next Year |
-1.720 |
PEG Ratio |
0.00 |
% Held by Insiders |
22.27 |
|
EPS Est. Next Quarter |
-0.480 |
Qtrly Rev. Growth |
-7.1 |
% Held by Institutions |
12.18 |
|
Forward EPS |
-1.717 |
Gross Profit (p.s.) |
0.087 |
Shares Short (K) |
1510 |
|
Book Value (p.s.) |
-0.140 |
EBITDA (p.s.) |
-1.826 |
P/E |
-0.94 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-19.86 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-18.90 |
P/S |
46810292.00 |
|
Operating Margin |
-404.13 |
Levered Free Cash Flow
(M) |
-10.92 |
P/CF |
-0.00 |
|
|
|
|
|
|
|
